Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Pfizer 15.034, Roche 17.5245.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Pfizer vs Roche: Revenue Comparison
Pfizer (PFE) and Roche (RHHBY) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $35.0B for Roche. Roche leads on revenue.
Pfizer's gross margin is 72.8% versus 73.7% for Roche. Pfizer's net margin is -1.6% versus 22.6% for Roche.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Roche.| Metric | Pfizer | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $35.05B |
| Cost of Revenue | $4.09B | $9.21B |
| Gross Profit | $10.94B | $25.84B |
| Operating Income | $4.71B | $10.90B |
| Net Income | $-246.00M | $7.93B |
| R&D Expense | $2.81B | $8.35B |
| Earnings Per Share | -$0.04 | $1.23 |
| Gross Margin | 72.8% | 73.7% |
| Operating Margin | 31.3% | 31.1% |
| Net Profit Margin | -1.6% | 22.6% |
| Free Cash Flow | $302.00M | $6.46B |
| Cumulative Free Cash Flow | $356.70B | $305.80B |
| Operating Cash Flow | $835.00M | $8.28B |
| Cash & Equivalents | $976.00M | $6.13B |